Sarepta Therapeutics, Inc.·4

Aug 6, 8:02 PM ET

Estepan Ian Michael 4

4 · Sarepta Therapeutics, Inc. · Filed Aug 6, 2025

Insider Transaction Report

Form 4
Period: 2025-08-05
Estepan Ian Michael
Chief Operating Officer
Transactions
  • Award

    Performance Stock Units

    2025-08-05+6,2506,250 total
    Common Stock (6,250 underlying)
Footnotes (1)
  • [F1]Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4